Convenient Synthesis of Furo[3,2-b]quinolin-4(1H)-ones

Veronika Králová; Miroslav Soural; Radim Horák; Pavel Hradil

doi:10.1055/s-0039-1691743

Synlett, Inhaltsverzeichnis

Synlett 2020; 31(09): 911-915
DOI: 10.1055/s-0039-1691743

letter

Convenient Synthesis of Furo[3,2-b]quinolin-4(1H)-ones

Veronika Králová ∗

^aDepartment of Organic Chemistry, Faculty of Science, Palacký University, 17. listopadu 12, 771 46 Olomouc, Czech Republic eMail: veronika.kralova@upol.cz

,

Miroslav Soural

^aDepartment of Organic Chemistry, Faculty of Science, Palacký University, 17. listopadu 12, 771 46 Olomouc, Czech Republic eMail: veronika.kralova@upol.cz

^bInstitute of Molecular and Translation Medicine, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 5, 779 00, Olomouc, Czech Republic

,

Radim Horák

^aDepartment of Organic Chemistry, Faculty of Science, Palacký University, 17. listopadu 12, 771 46 Olomouc, Czech Republic eMail: veronika.kralova@upol.cz

,

Pavel Hradil

^aDepartment of Organic Chemistry, Faculty of Science, Palacký University, 17. listopadu 12, 771 46 Olomouc, Czech Republic eMail: veronika.kralova@upol.cz

› Institutsangaben

Abstract

Alle Artikel dieser Rubrik

Abstract

In this work, we report the simple synthesis of furo[3,2-b]quinolin-4(1H)-ones from readily available 4-ethynyl-[1,3]dioxolo[4,5-c]quinolone as the key starting material. After Sonogashira (hetero)arylation, formation of the furoquinoline scaffold was accomplished using methanesulfonic acid and metal-free conditions. Although the cyclization was affected by the substitution of reaction intermediates, the method allowed the preparation of derivatives varying at the C3-position.

Keywords

furoquinolines - quinolines - cyclization - Sonogashira coupling

Volltext

Referenzen

References and Notes
1 Adamska-Szewczyk A, Glowniak K, Baj T. Curr. Issues Pharm. Med. Sci. 2016; 29: 33
2 Scala A, Cordaro M, Risitano F, Colao I, Venuti A, Sciortino MT, Primerano P, Grassi G. Mol. Divers. 2012; 16: 325
3 Wang B, Li Q, Shi W, Chen L, Sun J. Chem. Biol. Drug Des. 2018; 91: 957
4 Akula M, Yogeeswari P, Sriram D, Jha M, Bhattacharya A. RSC Adv. 2016; 6: 46073
5 Xiao Z, Waters NC, Woodard CL, Li Z, Li P.-K. Bioorg. Med. Chem. Lett. 2001; 11: 2875
6 Yamaguchi S, Tsuzuki K, Sannomiya Y, Oh-Hira Y, Kawase Y. J. Heterocycl. Chem. 1989; 26: 285
7 Sun N, Du R.-L, Zheng Y.-Y, Huang B.-H, Guo Q, Zhang R.-F, Wong K.-Y, Lu Y.-J. Eur. J. Med. Chem. 2017; 135: 1
8 Zhao M, Kamada T, Takeuchi A, Nishioka H, Kuroda T, Takeuchi Y. Bioorg. Med. Chem. Lett. 2015; 25: 5551
9 Bierer DE, Dubenko LG, Zhang P, Lu Q, Imbach PA, Garofalo AW, Phuan P.-W, Fort DM, Litvak J, Gerber RE, Sloan B, Luo J, Cooper R, Reaven GM. J. Med. Chem. 1998; 41: 2754
10 Lu YJ, Sun N, Huang ZS, Gu LQ. Chin. Chem. Lett. 2008; 19: 518
11 Rádl S, Konvička P, Váchal P. J. Heterocycl. Chem. 2000; 37: 855
12 Sundstrom TJ, Wright DL. Synlett 2010; 2875
13 Beccalli EM, Broggini G, Martinelli M, Paladino G, Zoni C. Eur. J. Org. Chem. 2005; 2091
14 Radchatawedchakoon W, Promthong N, Sakee U. Lett. Org. Chem. 2013; 10: 640
15 Patil MD, Liu R.-S. Org. Biomol. Chem. 2019; 17: 4452
16 Jean A, Rouden J, Maddaluno J, De Paolis M, Blanchet J. Tetrahedron Lett. 2019; 60: 534
17 Gharpure SJ, Nanda SK, Shelke YG. Chem. Eur. J. 2017; 23: 10007
18 Horak R, Koristek K, Samsulova V, Slaninova L, Grepl M, Kvapil L, Funk P, Hradil P, Soural M. J. Heterocycl. Chem. 2020;
19 Verma AK, Choudhary D, Saunthwal RK, Rustagi V, Patel M, Tiwari RK. J. Org. Chem. 2013; 78: 6657
20 Tang J, Xu B, Mao X, Yang H, Wang X, Lv X. J. Org. Chem. 2015; 80: 11108
21 Widner DL, Knauf QR, Merucci MT, Fritz TR, Sauer JS, Speetzen ED, Bosch E, Bowling NP. J. Org. Chem. 2014; 79: 6269
22 Yue D, Yao T, Larock RC. J. Org. Chem. 2006; 71: 62
23 Li J.-H, Zhang X.-D, Xie Y.-X. Synthesis 2005; 804
24 Hamm DC, Braun LA, Burazin AN, Gauthier AM, Ness KO, Biebel CE, Sauer JS, Tanke R, Noll BC, Bosch E, Bowling NP. Dalton Trans. 2013; 42: 948
25 Heidenreich RG, Kohler K, Krauter JG. E, Pietsch J. Synlett 2002; 1118
26 Novák Z, Szabó A, Répási J, Kotschy A. J. Org. Chem. 2003; 68: 3327
27 To a solution of alkyne 1 (200 mg, 0.54 mmol) in DMAC/H₂O (9.5/0.5; 950 μL/50 μL), 10% Pd/C (0.05 equiv, 0.027 mmol, 29 mg), PPh₃ (0.1 equiv, 0.054 mmol, 14 mg), CuI (0.1 equiv, 0.054 mmol, 10 mg), and DIPEA (3 equiv, 210 μL) were added. The reaction mixture was flushed with nitrogen, followed by addition of aryl or heteroaryl iodide (1 equiv). The reaction was heated to 70–75 °C and was monitored by TLC (hexane/EtOAc, 4:1). Upon completion (2–4 h), the reaction mixture was diluted with DCM and filtered through glass filter. Dark brown solution was evaporated, and the product was purified by column chromatography (hexane/EtOAc, 4:1 → EtOAc).Representative Product: 4-(Phenylethynyl)-[1,3]dioxolo[4,5-c]quinoline (2)Yield: 46%; mp 120–121 °C. ¹H NMR (400 MHz, DMSO-d ₆): δ = 7.96 (d, J = 8.7 Hz, 1 H), 7.83 (d, J = 8.2 Hz, 1 H), 7.67 (td, J = 7.7, 1.7 Hz, 3 H), 7.56–7.60 (m, 1 H), 7.49–7.53 (m, 3 H), 6.48 (s, 2 H). ¹³C NMR (101 MHz, DMSO-d ₆): δ = 149.1, 145.3, 142.1, 131.8, 129.9, 129.0, 128.9, 128.7, 127.3, 126.1, 120.9, 119.8, 115.1, 104.0, 93.4, 84.1. HRMS: m/z calcd for C₁₈H₁₁NO₂ [M + H]: 274.0863; found: 274.0863.
28 To a solution of alkyne 1 (1 equiv, 200 mg, 0.54 mmol) in acetonitrile (HPLC quality, 2 mL), PdCl₂(PPh₃)₂ (0.02 equiv, 0.01 mmol, 7.6 mg), CuI (0.01 equiv, 0.005 mmol, 1 mg), and Et₃N (3 equiv, 225 μL) were added. The reaction mixture was flushed with nitrogen, followed by addition of aryl or heteroaryl bromide/iodide (1 equiv). The reaction was heated to 50–55 °C and was monitored by TLC (hexane/EtOAc, 4:1). Upon completion (2–4 h), the reaction mixture was diluted with DCM and filtered through the glass filter. The dark brown solution was evaporated, and the product was purified by column chromatography (hexane/EtOAc, 4:1 → EtOAc).
29 To a solution of quinoline 1 (50 mg, 1 equiv) in dioxane (0.5 mL), methanesulfonic acid (5 equiv) and water in volume ratio 1:2 were added. The reaction mixture was heated to 85–90 °C in the pressurized tube until the disappearance of starting material (monitored by LC–MS). After that, the reaction mixture was quenched by water (4 mL), and pH was adjusted on 6–7 by 10% NaOH. The precipitated solid was filtered off, washed with water, and dried. The crude product was purified by stirring in chloroform.Furo[3,2-b]quinolin-9(4H)-one (21)Yield 60%, mp 180–183 °C. ¹H NMR (400 MHz, DMSO-d ₆): δ = 12.12 (s, 1 H), 8.24 (d, J = 8.2 Hz, 1 H), 8.14 (s, 1 H), 7.55–7.65 (m, 2 H), 7.26 (t, J = 7.3 Hz, 1 H), 6.86 (s, 1 H). ¹³C NMR (101 MHz, DMSO-d ₆): δ = 164.0, 149.9, 139.6, 137.9, 137.5, 131.3, 125.4, 124.5, 121.4, 117.9, 102.3. HRMS: m/z calcd for C₁₁H₇NO₂ [M + H]: 186.0550; found: 186.0551.
30 Alabugin VI, Gonzalez-Rodriguez E, Kawade KR, Stepanov AA, Vasilevsky FS. Molecules 2019; 24: 1036

Zusatzmaterial

Supporting Information